extended-release

extended-release 基本解释

网络  缓释制剂; 缓释; 缓释释放; 缓释型; 延长释放

医学

重点词汇

• releasen. 释放, 发泄, 豁免, 发行, 释放证书 vt. 释放, 解除, 放松, 豁免, 免除, 发布, 放弃, 让与 n. 发布 [计] 版本, 发布
• extendeda. 延续的, 伸出的, 竭尽全力的, 广大的, 扩大范围的 [法] 展期的, 延期的, 延长的

extended-release 双语例句

1. 1、 Early last year, the FDA approved dalfampridine extended-release tablets to help MS patients with walking.
   去年初，食品和药品管理局批准使用钾通道阻滞剂缓释片来帮助改善多发性硬化症患者行走。
2. 2、 Because it was a small study, the team said more research is needed to see if diabetics will benefit from getting extended-release niacin, such as Niaspan made by Abbott Laboratories Inc.
   研究小组说，因为这是一个小型研究，有必要采取更多的研究来阐明糖尿病患者是否将通过服用烟酸缓释片受益，如由雅培公司生产的烟酸控释制剂。
3. 3、 Relative hazard reductions favored the combination of aspirin plus extended-release dipyridamole.
   合并用药组也可获致较多的相关危害风险降低量；
4. 4、 Efficacy and safety of paliperidone extended-release tablets in treatment of patients with schizophrenia: a randomized, controlled study
   帕利哌酮缓释片对精神分裂症疗效及安全性的对照研究
5. 5、 Preparation and in vitro release property of loxoprofen sodium extended-release effervescent tablets
   洛索洛芬钠缓释泡腾片的制备及体外释放特性
6. 6、 Naltrexone extended-release injectable suspension is the first and currently the only once-monthly injectable medication for alcohol dependence.
   纳曲酮缓释注射用混悬剂是首个也是目前仅有的每月注射一次用于治疗酒精依赖的药物。
7. 7、 Table II: Polyethylene oxide extended-release formulations used in the study.
   表二：在研究中使用的聚乙烯氧化缓释配方。
8. 8、 The FDA is requiring that a medication guide about treatment with naltrexone extended-release injectable suspension be provided to all patients.
   FDA正在要求制订一份可提供给所有患者的有关使用纳曲酮缓释注射用混悬剂治疗的用药指南。
9. 9、 In vitro release of compound niacin extended-release and simvastatin immediate-release double-layer tablets
   复方烟酸辛伐他汀双层片体外释放度的研究
10. 10、 Bioavailability of Single Oral Dose of Galanthamine Hydrobromide extended-release Pellet Capsule in Dogs
    家犬单剂量口服氢溴酸加兰他敏缓释微丸胶囊的生物利用度研究
11. 11、 In oral products, HPMC is primarily used as a tablet binder, in film coating, and as an extended-release tablet matrix.
    在口头产品，HPMC主要被使用作为片剂黏合剂，在包衣涂层，并且作为延长释放的药片包衣。
12. 12、 Determination of Release of Felodipine extended-release Tablets in Vitro by HPLC Studies on the analysis process for dissolution of diclofenac sodium sustained release tablets
    HPLC法测定非洛地平缓释片释放度的探讨双氯芬酸钠缓释片体外实时释放的研究
13. 13、 Next, they divided up the diabetics and gave half a placebo and treated half with extended-release niacin, a drug that raises HDL levels in the blood.
    接下来，他们将糖尿病患者进行平均分组，一组给予安慰剂，一组给予烟酸缓释片，后者可提高血液中HDL的水平。
14. 14、 extended-release metformin in treatment of patients with type 2 diabetes: efficacy and safety
    盐酸二甲双胍缓释片治疗2型糖尿病的疗效及安全性分析
15. 15、 Methylphenidate extended-release tablets exert different effects on different detailed function.
    其对各种细化功能改善的效果有所不同。
16. 16、 Objective To evaluate the correlation between absorption in vivo and dissolution in vitro of extended-release tablet of ciprofloxacin hydrochloride.
    目的对盐酸环丙沙星缓释片体外释放与体内吸收的相关性进行研究。
17. 17、 OBJECTIVE To observe release and curative charge of different formulas of felodipine extended-release tablets.
    目的观察非洛地平缓释片体外释放度和治疗效果分析。
18. 18、 Studies on extended-release Tablets of Niacin and Lovastatin Compound
    复方烟酸和洛伐他汀缓释片的研究
19. 19、 Study on drug release from mitoxantrone polylactic acid extended-release nanoparticles in vitro
    米托蒽醌聚乳酸缓释毫微粒冻干针剂的体外释药特性研究
20. 20、 Conclusion Gliclazide EPC has good effect of extended-release in vitro and the release behavior in vivo need to be inspected.
    结论格列齐特缓释微丸胶囊具有良好的体外缓释效果，可进一步进行体内释药行为考察。
21. 21、 Study on Preparation and Dissolution Test in Vitro of Gliclazide extended-release Pellet Capsule
    格列齐特缓释微丸胶囊的制备及体外释放度考察格列齐特缓释微丸胶囊的研制
22. 22、 This matrix system ( BPR-HPMC extended release Tablets, BPR-HPMC) shows some characterization of extended-release, for example, Buspirone Hydrochloride release in vitro 24 for hours.
    结果表明BPR-HPMC缓释片具备了缓释制剂的某些特点，比如盐酸丁螺环酮体外持续释放达24h，该缓释片存在的缺点是在2h之前药物释放太快。
23. 23、 HPLC Determination of the Content of Fluvastatin Sodium extended-release Tablets
    高效液相色谱法测定氟伐他汀钠缓释片的含量
24. 24、 Objective To compare the efficacy and tolerability of methylphenidate extended-release tablets ( OROS MPH) and placebo in treating children with attention deficit hyperactivity disorder ( ADHD).
    目的比较盐酸哌甲酯控释片与安慰剂治疗儿童注意缺陷多动障碍（ADHD）的疗效及安全性。
25. 25、 The release behavior of gliclazide EPC coincidented with Higuchi equation well and the character of extended-release was transparent.
    释药行为符合Higuchi方程，具有明显的缓释特征。
26. 26、 Objective To study the pharmacokinetics of compound niacin extended-release tablets in beagle dogs and bioequivalence.
    目的研究复方烟酸缓释片在beagle犬体内的缓释成分烟酸的药代动力学和生物等效性。
27. 27、 Objective To study prescription and technique of gliclazide extended-release pellet capsule ( EPC) and to inspect release property in vitro.
    目的对格列齐特缓释微丸胶囊的处方和工艺进行研究，并考察其体外释放度。
28. 28、 It shows that the synthetic method of the PCL we taken has good repetition and high productivity and that the PCL is safety, and also the buspirone extended-release tablet has idealized drug-release behavior in vitro.
    研究结果表明采用文中方法合成的聚己内酯安全无毒，具有良好的工艺重复性和收率；所制缓释片有满意的释药行为。